The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study

Chronic obstructive pulmonary disease (COPD), a complex progressive disease, is currently the third leading cause of death worldwide. One recommended treatment option is fixed-dose combination therapy of an inhaled corticosteroid (ICS)/long-acting β-agonist. Clinical trials suggest pressurized meter...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Rupert, Martin, Jessica, Thomas, Vicky, Skinner, Derek, Marshall, Jonathan, Stagno d’Alcontres, Martina, Price, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566416/
https://www.ncbi.nlm.nih.gov/pubmed/28860739
http://dx.doi.org/10.2147/COPD.S141409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566416/
https://www.ncbi.nlm.nih.gov/pubmed/28860739
http://dx.doi.org/10.2147/COPD.S141409

Ejemplares similares